Want to see HK:3600 full AI Analyst Report?
3600 Stock Chart & Stats
HK$5.43
HK$0.05(1.24%)
At close: 4:00 PM EST
HK$5.43
HK$0.05(1.24%)
Day’s Range― - ―
52-Week RangeHK$4.10 - HK$7.10
Previous CloseN/A
Volume218.00K
Average Volume (3M)704.15K
Market Cap
HK$6.45B
Enterprise ValueHK$5.34B
Total Cash (Recent Filing)HK$767.24M
Total Debt (Recent Filing)HK$654.11M
Price to Earnings (P/E)11.1
Beta0.37
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.65%
Share Statistics
EPS (TTM)0.63
Shares Outstanding934,850,000
10 Day Avg. Volume687,288
30 Day Avg. Volume704,147
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.52
Price to Sales (P/S)1.34
P/FCF Ratio7.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.66
Revenue Forecast (FY)HK$4.13B
Bulls Say, Bears Say
Bulls Say
Robust Cash GenerationStrong operating cash flow and high free cash flow provide durable internal funding for capex, dividends, and debt reduction. Sustained cash conversion close to earnings improves financial flexibility, reduces reliance on external financing, and supports strategic reinvestment over the medium term.
Meaningful Margin ExpansionMaterial margin improvement reflects stronger pricing power and operational leverage in laboratory operations. Higher and sustainable margins increase cash generation per case, improve return on invested capital, and create a structural buffer that supports profitability even with moderate revenue fluctuations.
Improving Balance Sheet LeverageProgressively lower leverage paired with rising equity and stronger ROE improves solvency and reduces interest burden risk. A healthier capital structure increases capacity for M&A, capex, or shareholder returns and enhances resilience to cyclical downturns over the next several quarters.
Bears Say
Historical Revenue And Cash VolatilityPast volatility, including a 2022 revenue decline and intermittent weak cash conversion, signals structural sensitivity to demand and working-capital swings. This reduces predictability of free cash flow and complicates multi-quarter capital allocation and debt-servicing planning.
Revenue Sensitivity To Case Volumes And MixThe business model ties revenue and margins tightly to case throughput and product mix. Durable risks include dental demand cycles, competitive pricing pressure, and shifts toward different product mixes or lower-margin offerings, which can structurally depress revenue and margins across quarters.
Absolute Debt And ROE VolatilityAlthough leverage ratios improved, absolute debt levels remain material and ROE has fluctuated. In an economic slowdown, fixed debt obligations could constrain cash and limit investment or shareholder returns, making sustained profitability critical to maintaining financial flexibility.
Modern Dental Group Limited News
3600 FAQ
What was Modern Dental Group Limited’s price range in the past 12 months?
Modern Dental Group Limited lowest stock price was HK$4.10 and its highest was HK$7.10 in the past 12 months.
What is Modern Dental Group Limited’s market cap?
Modern Dental Group Limited’s market cap is HK$6.45B.
When is Modern Dental Group Limited’s upcoming earnings report date?
Modern Dental Group Limited’s upcoming earnings report date is Sep 01, 2026 which is in 49 days.
How were Modern Dental Group Limited’s earnings last quarter?
Modern Dental Group Limited released its earnings results on Mar 26, 2026. The company reported HK$0.334 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.334.
Is Modern Dental Group Limited overvalued?
According to Wall Street analysts Modern Dental Group Limited’s price is currently Overvalued.
Does Modern Dental Group Limited pay dividends?
Modern Dental Group Limited pays a Quarterly dividend of HK$0.15 which represents an annual dividend yield of 3.65%. See more information on Modern Dental Group Limited dividends here
What is Modern Dental Group Limited’s EPS estimate?
Modern Dental Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modern Dental Group Limited have?
Modern Dental Group Limited has 934,850,000 shares outstanding.
What happened to Modern Dental Group Limited’s price movement after its last earnings report?
Modern Dental Group Limited reported an EPS of HK$0.334 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.683%.
Which hedge fund is a major shareholder of Modern Dental Group Limited?
Currently, no hedge funds are holding shares in HK:3600
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Modern Dental Group Limited
Modern Dental Group Limited, an investment holding entity, is a prominent provider specializing in the manufacturing and worldwide distribution of dental prosthetic devices. Its extensive operations reach various international markets, including Europe, Greater China, North America, and Australia. The company's offerings are structured across three primary segments. The Fixed Prosthetic Devices division provides restorative dental solutions such as crowns, bridges, and implants. Concurrently, the Removable Prosthetic Devices segment is dedicated to producing both full and partial dentures, which can include metal frameworks or be entirely metal-free. Furthermore, its "Others" segment encompasses a diverse range of products like orthodontic appliances, sports guards, anti-snoring devices, raw materials, and various dental equipment. This segment also extends to offering professional services, including educational events and seminars. Modern Dental Group serves a broad clientele comprising dentists, dental clinics, hospitals, distributors, and other professional customers. Its comprehensive product line is marketed under numerous recognized brands, such as Permadental & Semperdent, Schmidt, Apex Digital Dental, Elysee, Labocast, Modern Dental Laboratory, Yangzhijing, Southern Cross Dental, Andent, Modern Dental USA, Sundance Dental, Quantum Dental, TrioClear, and Digitek Dental. The company was established in 1986 and is headquartered in Kowloon, Hong Kong.
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
PW Medtech Group Ltd.
―
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Angelalign Technology Inc.
―
Options Prices
Currently, No data available
---